Evidence map›Paper›PMID 29179866›Full record

ArticlePapillomavirus research (Amsterdam, Netherlands)2017

miRNA-expression in tonsillar squamous cell carcinomas in relation to HPV infection and expression of the antileukoproteinase SLPI.

Elgar Susanne Quabius, Immanuel Merz, Tibor Görögh, Jürgen Hedderich, Jochen Haag, Christoph Röcken, Petra Ambrosch, Markus Hoffmann

Open access · goldAbstract read
In one paragraph

Article in Papillomavirus research (Amsterdam, Netherlands), 2017. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 7 papers.

0numbers the graph read from it
0cells of the map it votes in
7citing papers in PubMed
0.2field-weighted citation impact, top 49% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

7 citing papers in PubMed, 12 citations in OpenAlex.

  1. Review
  2. Dysregulated microRNA Expression Relevant toLife (Basel, Switzerland) · 2023
    Article
  3. Review
  4. Review
  5. Article
  6. Review
  7. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors at 1 institution in 1 country.

Elgar Susanne QuabiusDepartment of Otorhinolaryngology, Head and Neck Surgery, Christian-Albrechts-University Kiel, Germany; Institute of Immunology, Christian-Albrechts-University Kiel, Germany. Electronic address: ElgarSusanne.Quabius@uksh.de.
Immanuel MerzDepartment of Otorhinolaryngology, Head and Neck Surgery, Christian-Albrechts-University Kiel, Germany.
Tibor GöröghDepartment of Otorhinolaryngology, Head and Neck Surgery, Christian-Albrechts-University Kiel, Germany.
Jürgen HedderichInstitute for Medical Informatics and Statistics, Christian-Albrechts-University Kiel, Germany.
Jochen HaagInstitute for Pathology, Christian-Albrechts-University Kiel, Germany.
Christoph RöckenInstitute for Pathology, Christian-Albrechts-University Kiel, Germany.
Petra AmbroschDepartment of Otorhinolaryngology, Head and Neck Surgery, Christian-Albrechts-University Kiel, Germany.
Markus HoffmannDepartment of Otorhinolaryngology, Head and Neck Surgery, Christian-Albrechts-University Kiel, Germany.
Kiel University · DE

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

The aim of this study was to determine if micro-(mi-)RNAs are involved in the previously reported inverse correlation between the antileukoproteinase SLPI, HPV, and smoking habit of head and neck squamous cells carcinoma (HNSCC) patients. HPV-status and SLPI-protein expression were determined in tonsillar SCC (TSCC; n=126). Differentially expressed miRNAs dependent on HPV-status and SLPI-expression were detected by microarray; possible binding-sites in SLPI- and HPVE6-mRNAs were determined in silico. Survival rates were estimated testing prognostic values of HPV-status, SLPI- and miRNA-expression. miRNA-array identified 24 up-regulated and 10 down-regulated miRNAs in HPV-positive versus HPV-negative TSCC (p<0.01; HPV-positivity: 42.1%). HPV-positivity resulted in two up-regulated miRNAs in SLPI-positive TSCC. Of 16 further miRNAs, eight miRNAs were up- and eight were down-regulated in SLPI-negative TSCC. RT-q-PCR-validation of the four most differentially expressed miRNAs showed that miR-363 is expressed strongest in SLPI-negative/HPV-positive TSSC. In silico-analysis of all differentially expressed miRNAs identified miR-363, miR-210, miR-130a, and miR-181a with possible binding sites in the HPV16-E6-mRNA, but none were predicted in the SLPI-mRNA. HPV-positivity, low SLPI-levels and high miR-363-levels are significantly associated with better survival rates. The data presented here show that miR-363 is associated with HPV-positive/SPLI-negative TSCC. The prognostic value of miR-363 suggests a role in the assumed inverse correlation of smoking and SPLI-expression in the mode of HPV-infections in tonsillar but possibly also other HNSCC.

Indexed as

AdultAgedAged, 80 and overBinding SitesCarcinoma, Squamous CellComputer SimulationDown-RegulationFemaleGene ExpressionHumansMaleMicroarray AnalysisMicroRNAsMiddle AgedPapillomaviridaePapillomavirus InfectionsMicroRNAsMIRN3656 microRNA, humanSecretory Leukocyte Peptidase InhibitorSLPI protein, humanHNSCCHPV, miRNASLPISurvivalTonsils

Identifiers

PMID29179866
PMCPMC5883217
OpenAlexW2625706354

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.